|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Patients with scans without evidence of dopaminergic deficit: a long term follow up study显示文摘 | Batla A Stamelou M Bhatia KP | 2014 | Mov Disord2014，29，14： | 1 |
| 2 | Hemifacial spasm: clinical characteristics of 321 Indian patients 显示文摘 | Batla A Goyal C Shukla G | 2012 | J Neurol2012，259，8： | 1 |
| 3 | Treatment of focal dystonia显示文摘 | Batla A Stamelou M Bhatia KP | | 0，，： | 1 |
| 4 | Markedly asymmetric presentation in multiple system atrophy 显示文摘 | Batla A Stamelou M Mensikova K | 2013 | Parkinsonism Relat Disord2013，19，10： | 1 |
| 5 | Hemifacial spasm:clinical characteristics of 321 Indian patients显示文摘 | Batla A Goyal C5Shukla G | 2012 | Journal of neurolo gy2012，259，8： | 1 |
| 6 | Hemifacial spasm: clinical characteristics of 321 Indian patients显示文摘 | Batla A Goyal C Shukla G | 2012 | J Neurol2012，259，： | 1 |
| 7 | Posterior circulation stroke as the initial manifestation of cranio-vertebral junction anomaly with atlanto-ax- ial dislocation显示文摘 | Khwaja GA Batla A Gupta M | 2011 | J Indian Acad Clin Meal2011，12，1： | 1 |
| 8 | Synthesis of 1,3-diaryl-7,7'-diethyl-5-methyl-4-oxo-2-thioxo-1,2,3,4-tetra- hydro-7 H-pyrano pyrimidines显示文摘 | Ahluwalia V K Batla R Khurana A | 1990 | Indian J Chem1990，29，12： | 1 |
| 9 | Treatment of focal dysto-nia显示文摘 | Batla A Stamelou M Bhatia KP | | 0，，03： | 1 |
| 10 | Stem cells and the pursuit of youth,a tale of limitless possibilities and commercial fraud显示文摘This article examines the hype generated around the term“stem cell”,and the capitalization of the stem cell craze by the cosmetic industry.It started by introducing product lines containing active ingredients derived from plant stem cells.Then,evolved to using own cells for skin regeneration and hair loss treatment,and allogenic cells for the manufacturing of stem cell-derived products.This article also discusses the missing links for safe and reliable stem cell applications in cosmetics,and why local regulatory bodies,members of the industry and consumers must all work together to stop the illegitimate use of the“stem cell”good name in unsafe or fraudulent commercial practices. | Batla S Al-Sowayan Alaa T Al-Shareeda | 2021 | World Journal of Biological Chemistry2021，12，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员